Pharma Mirror

JANUARY 1, 2023

by Dr Torill Bigg, Chief Carbon Reduction Engineer at Tunley Engineering Businesses globally are looking to reduce their carbon footprints. A number of factors is driving this activity. It is a smart and ethical business practice to operate sustainably for the environment and for grand success. Demonstrating environment leadership enhances business reputation, retains and attracts customers, investors, and staff – and enhances market value.

Engineer 130

Engineer Marketing 130

NPR Health - Shots

JANUARY 1, 2023

In Fairfax County, Va., the health department is training high school students to become health ambassadors in underserved communities and get a leg up on future careers in public health.

129

129

STAT News

JANUARY 1, 2023

The Congressional report on the FDA’s approval of Aduhelm makes some good points. As regulatory science advances, so too must the FDA’s administrative procedures. But this report mustn’t be seen as an excuse for the agency to hew to a 20th century view of drug development and review. The FDA and the industries it regulates must work together to facilitate innovation that results in new and important medical technologies like Aduhelm and other medicines currently in the pipel

Regulation 98

Regulation Medicine Development Drugs 98

Medical Xpress

JANUARY 1, 2023

Travellers from China now face restrictions when entering more than a dozen countries as concern grows over its surge in COVID-19 cases, with Australia the latest to demand a negative test before arrival.

94

94

Advertisement

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

Clinical Research

NPR Health - Shots

JANUARY 1, 2023

The start of a new year often means one thing: New Year's resolutions. But what's the best way to make sure you actually follow them? Life Kit has some tips.

69

69

Medical Xpress

JANUARY 1, 2023

EU countries will meet next week to discuss a joint response to travellers from China amid concern over the country's explosion of Covid cases, incoming EU presidency holder Sweden announced Saturday.

90

90

Drug Discovery World

JANUARY 1, 2023

2022 was a complicated year. Global challenges like the Ukraine war and the continued impact of Covid-19 have been felt across the world. And yet it was also a year of incredible innovation in drug discovery, with the potential of new biotechnology beginning to be revealed. Our top 10 most popular online articles for 2022 [.]. To read this content in full, you need to login.

Drugs 52

Drugs Gene Therapy Gene Vaccination 52

Drug Patent Watch

JANUARY 1, 2023

[![eltrombopag structure]([link] Eltrombopag is the generic ingredient in two branded drugs marketed by Novartis and is included in two NDAs. There are eight patents protecting this compound. There are four…. The post New tentative approval for Teva Pharms drug eltrombopag appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52

Drugs Branding Marketing 52

ECRG Media's Clinical Research Podcast

JANUARY 1, 2023

Trying to Become a CRA During a Pandemic. Don't forget to Subscribe for new content! Merch: [link] Subscribe: [link] Email: eliteclinicalgroup@gmail.com Podcast: [link] Steemit: [link] Advertise: eliteclinicalgroup@gmail.com Watch: » Industry News: [link] » All Videos: [link] » Interview Recaps: [link] » Glassdoor Reviews: [link] We do: » Insider Interviews » Resume Reviews » Question and Answer » Discuss all things Clinical Research » News and Product Reviews » Education.

Clinical Research 52

Clinical Research Production Research 52

Drug Patent Watch

JANUARY 1, 2023

[![saxagliptin structure]([link] Saxagliptin is the generic ingredient in one branded drug marketed by Astrazeneca Ab and is included in one NDA. There are two patents protecting this compound. There are…. The post New tentative approval for Amneal Pharms drug saxagliptin appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52

Drugs Branding Marketing 52

Advertisement

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

Clinical Trials

Drug Patent Watch

JANUARY 1, 2023

VANOS (fluocinonide) Bausch Patent: 7,220,424 Expiration: Jan 7, 2023 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit…. The post Drug Patent Expirations for the Week of January 1, 2023 appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 40

Drugs 40

Drug Patent Watch

JANUARY 1, 2023

This chart shows the pharmaceutical companies with the most patents in Israel. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…. The post Which pharmaceutical companies have the most drug patents in Israel? appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 98

Drugs 98